Loading…
Lobbying Income
—
Filings
94
Unique Clients
1
Active Period
2004–2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2026 · third_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $1,020,000 · Firm income: —
Matched citations: H.R. 1492
PAW Act of 2025
2026 · third_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Farm, Food and National Security Act of 2026 (H.R. 7567) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Client expense: $1,020,000 · Firm income: —
Matched citations: H.R. 1842
Farm, Food, and National Security Act of 2026
2026 · third_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Farm, Food and National Security Act of 2026 (H.R. 7567) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Client expense: $1,020,000 · Firm income: —
Matched citations: H.R. 7567
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
2026 · third_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $1,020,000 · Firm income: —
Matched citations: H.R. 842
ORPHAN Cures Act
2026 · third_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $1,020,000 · Firm income: —
Matched citations: H.R. 946
ORPHAN Cures Act
2026 · third_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $1,020,000 · Firm income: —
Matched citations: S. 1862
A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
2026 · third_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $1,020,000 · Firm income: —
Matched citations: S. 339
EPIC Act of 2025
2026 · third_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $1,020,000 · Firm income: —
Matched citations: S.832
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2026 · second_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $710,000 · Firm income: —
Matched citations: H.R. 1492
PAW Act of 2025
2026 · second_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Farm, Food and National Security Act of 2026 (H.R. 7567) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Client expense: $710,000 · Firm income: —
Matched citations: H.R. 1842
Farm, Food, and National Security Act of 2026
2026 · second_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Farm, Food and National Security Act of 2026 (H.R. 7567) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Client expense: $710,000 · Firm income: —
Matched citations: H.R. 7567
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
2026 · second_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $710,000 · Firm income: —
Matched citations: H.R. 842
ORPHAN Cures Act
2026 · second_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $710,000 · Firm income: —
Matched citations: H.R. 946
ORPHAN Cures Act
2026 · second_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $710,000 · Firm income: —
Matched citations: S. 1862
A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
2026 · second_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $710,000 · Firm income: —
Matched citations: S. 339
EPIC Act of 2025
2026 · second_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $710,000 · Firm income: —
Matched citations: S.832
Student Loan Tax Elimination Act
2026 · first_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Client expense: $1,165,000 · Firm income: —
Matched citations: H.R. 1842
Farm, Food, and National Security Act of 2024
2026 · first_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Client expense: $1,165,000 · Firm income: —
Matched citations: H.R. 8467
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2026 · first_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $1,165,000 · Firm income: —
Matched citations: H.R. 1492
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
2026 · first_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $1,165,000 · Firm income: —
Matched citations: H.R. 842
ORPHAN Cures Act
2026 · first_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $1,165,000 · Firm income: —
Matched citations: H.R. 946
ORPHAN Cures Act
2026 · first_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $1,165,000 · Firm income: —
Matched citations: S. 1862
A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
2026 · first_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $1,165,000 · Firm income: —
Matched citations: S. 339
EPIC Act of 2025
2026 · first_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client expense: $1,165,000 · Firm income: —
Matched citations: S.832
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
2025 · second_quarter · Client: BOEHRINGER INGELHEIM USA CORPORATION
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Client expense: $990,000 · Firm income: —
Matched citations: H.R. 3419
Source: Senate LDA